Browse Category

Stock Market News 7 December 2025

VIX Index Today, December 7, 2025: What the Market’s Fear Gauge Is Signaling Now

VIX Index Today, December 7, 2025: What the Market’s Fear Gauge Is Signaling Now

As of December 7, 2025, the Cboe Volatility Index (VIX) – Wall Street’s classic “fear gauge” – is sitting in the mid‑teens after a sharp retreat from November’s volatility spikes. The latest trade data show spot VIX around 15.4, down roughly 12–13% so far in December, and well below the panic peaks above 26 seen just a few weeks ago. Fortune+3Cboe Global Markets+3Investing.com+3 That mix of calmer volatility and still‑elevated macro risks makes the VIX index a crucial number to watch for anyone trading stocks, options, or VIX-linked products. Key Takeaways for December 7, 2025 What Exactly Is the VIX
7 December 2025
RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

Red Cat Holdings (NASDAQ: RCAT) is back in the spotlight. The defense‑drone specialist has just reshuffled its leadership team, posted explosive revenue growth, drawn fresh institutional money—and still trades well below its 2025 highs. As of the close on Friday, December 5, 2025, RCAT stock finished at $8.02, giving Red Cat a market capitalization of roughly $957 million. The shares sit about 75% above their 52‑week low of $4.58 and roughly 52% below the high of $16.70 set in October. MarketBeat+1 Here’s a deep dive into the latest RCAT news, Wall Street forecasts, and what it all might mean for
REIT Stock Prices on December 7, 2025: Are Rate Cuts Setting Up a 2026 Rally?

REIT Stock Prices on December 7, 2025: Are Rate Cuts Setting Up a 2026 Rally?

Real estate investment trusts (REITs) are ending 2025 in that familiar place where markets get interesting: fundamentals looking solid, prices still a bit grumpy, and interest rates finally moving in the right direction for landlords. As of the latest close on Friday, December 5, the FTSE Nareit All REITs Index slipped a marginal 0.11%, while equity REITs and mortgage REITs diverged slightly: the All Equity REITs Index was down 0.09%, but the Mortgage REITs Index rose 0.38%.Reit.com In ETF land, the widely followed Vanguard Real Estate ETF (VNQ) finished Friday at $89.88, down 0.11% on the day and about 6%
Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

As of December 7, 2025, WBA stock is no longer a normal stock at all. Walgreens Boots Alliance has been taken private by Sycamore Partners, its shares have been delisted from Nasdaq, and the old “WBA” ticker is now basically a historical artifact. Walgreens Boots Alliance+2Stock Titan+2 Yet WBA keeps popping up in headlines — from a December 3 data breach to fresh analysis of its store real estate and even AI-driven “technical signals” published on December 6. Breachsense+2Commercial Observer+2 This piece rounds up the latest news, forecasts and analyses as of 07.12.2025 (December 7, 2025) and explains what that
VOO Stock Today: Vanguard S&P 500 ETF Near Record Highs as Inflows Smash All‑Time Records (December 7, 2025)

VOO Stock Today: Vanguard S&P 500 ETF Near Record Highs as Inflows Smash All‑Time Records (December 7, 2025)

Updated December 7, 2025 The Vanguard S&P 500 ETF (ticker: VOO) is ending 2025 in a position most index funds can only daydream about. The fund is trading around $630 per share, close to its 52‑week high and sitting on record‑breaking inflows that have turned it into the largest ETF in the world. The Motley Fool+1 At the same time, Wall Street’s 2026 forecasts for the S&P 500 — and therefore VOO — are broadly optimistic but layered with warnings about high valuations, interest rates, and concentration in mega‑cap tech. Morgan Stanley+2RBC Wealth Management – Asia+2 Here’s a deep dive
7 December 2025
ANET Stock Forecast: Why Analysts Still See Big Upside for Arista Networks After Its Latest Pullback

ANET Stock Forecast: Why Analysts Still See Big Upside for Arista Networks After Its Latest Pullback

Updated December 7, 2025 Arista Networks (NYSE: ANET) has cooled off after a powerful multi‑year run, but Wall Street still expects sizable upside as the AI data‑center build‑out continues. After a recent correction, ANET is trading around $129 per share, roughly 22% below its 52‑week high near $165, but still more than double its 52‑week low around $59.Ticker Nerd Most analysts covering the stock still rate it a “Strong Buy”, with 12‑month price targets clustered in the mid‑$160s to low‑$170s, implying roughly 27–30% upside from current levels.WallStreetZen+2StockAnalysis+2 Below is a deep dive into the latest ANET stock news, forecasts and
ServiceNow (NOW) Stock on December 7, 2025: Stock Split, Veza Deal and 2025 Outlook for the AI Workflow Leader

ServiceNow (NOW) Stock on December 7, 2025: Stock Split, Veza Deal and 2025 Outlook for the AI Workflow Leader

As of December 7, 2025, ServiceNow (NYSE: NOW) sits at the crossroads of three big storylines:a looming 5‑for‑1 stock split, a push deeper into identity security via the Veza acquisition, and an AI‑driven growth engine that is still humming even as investors worry about valuation and macro risk. Shares of ServiceNow trade around $854 per share, giving the company a market value in the high‑$100‑billion range.GuruFocus The stock has been volatile: up strongly over the last three years, but down double‑digits year‑to‑date and over the past 12 months as investors recalibrate how much they are willing to pay for high‑multiple
INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

Published: December 7, 2025 Inovio Pharmaceuticals (NASDAQ: INO) has quietly turned 2025 into a make‑or‑break year. The small‑cap biotech has completed a Biologics License Application (BLA) for its lead DNA immunotherapy INO‑3107, raised fresh capital through two stock offerings, and attracted a flurry of new analyst ratings and algorithmic “Strong Buy” labels — all while still burning cash and generating minimal revenue. GuruFocus+3Yahoo Finance+3Stock Titan+3 As of the last trading session on Friday, December 5, 2025, INO stock closed at $2.07, up about 2.5% on the day and roughly 19–20% over the past 10 trading sessions, with around 1 million
Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Ticker: LUV – Coverage date: December 7, 2025 Southwest Airlines stock is back in the spotlight. As of the close on Friday, December 5, 2025, shares of Southwest Airlines Co. (NYSE: LUV) finished just under $38, near a new 52‑week high, after rallying roughly 20% over the past month and about 12–13% year to date.MarketBeat+1 The catch: this surge comes right after the airline cut its 2025 profit outlook because of a 43‑day U.S. government shutdown and higher fuel costs—and just as U.S. regulators waive an $11 million fine tied to Southwest’s infamous 2022 holiday meltdown.Reuters+1 Here’s a detailed look
7 December 2025
CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (NASDAQ: CLSK) has quietly turned into one of the loudest volatility machines in U.S. small caps: a Bitcoin miner, an emerging AI infrastructure play, and a stock that can move nearly 10% in a day without breaking a sweat. As of the close on December 5, 2025, CLSK traded around $13.7 per share, down roughly 8–9% on the day on very heavy volume of about 32–33 million shares. The selloff followed the release of “transformative” fiscal 2025 results that delivered triple‑digit revenue growth and a swing to substantial profit – but also missed Wall Street estimates and came with
KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

Updated: December 7, 2025 – Ticker: KULR (NYSE American) KULR Stock Snapshot: Price, Market Cap, and Volatility At the start of December 2025, KULR Technology Group’s share price is hovering around $3.93, with recent trading showing an intraday range between roughly $3.78 and $3.99 and volume around 1.36 million shares. That puts the company’s market capitalization near $180 million. Stock Titan Those calm-looking numbers sit on top of a pretty wild story: In other words, KULR is not a sleepy industrial. It’s a mash‑up of space‑grade battery tech and a leveraged Bitcoin balance sheet, and the stock trades accordingly. What
BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP stock is ending the first week of December in a strange but familiar place: cash is pouring out to shareholders, the share price is recovering, analysts are split, and the long‑term energy transition story is getting messier. As of the close on 5 December 2025, BP’s New York–listed ADRs (NYSE: BP) traded around $35.8 per share, while the London‑listed stock (LSE: BP.) changed hands at about 453p, putting the UK shares up roughly 18% over the past year.StockAnalysis+1 TradingView estimates BP’s dividend yield at about 5.4%, cementing its status as a high‑income name in the FTSE 100.TradingView Yet on
7 December 2025
Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Published: December 7, 2025 Nike’s stock has had a choppy 2025, and as of early December the story is less about sneakers and more about strategy: a leadership overhaul, pressure in China, a fresh dividend increase and a market still trying to decide whether NKE is a turnaround play or a value trap. Nike (NKE) Stock Price Snapshot Today Nike’s Class B shares (ticker: NKE) are trading around $65.86 per share, giving the company a market capitalization of roughly $97 billion. Google Key snapshot metrics as of this week: According to Zacks, the stock is down about 11% over the
7 December 2025
StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

As of December 7, 2025, sneakerheads, collectors and private‑market investors are all watching the same thing: “StockX stock”—even though the company still isn’t publicly listed on any exchange. StockX, the Detroit‑based marketplace that brands itself as the “stock market of things,” remains a private, venture‑backed company. But a growing ecosystem of pre‑IPO platforms, secondary brokers and data providers now publishes daily “StockX stock prices” and valuation estimates, and the company has just wrapped a busy 2025 filled with new products, legal milestones and impressive marketplace growth. AltInvests+1 This article pulls together the latest prices, news, forecasts and analyses around StockX
7 December 2025
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt offering, secured fresh regulatory wins in its cardiopulmonary and animal-health franchises, boosted its dividend, and simultaneously ran into a new patent roadblock for its subcutaneous Keytruda injection in Germany. PR Newswire+4Wikipedia+4Stock Titan+4 Against that backdrop, MRK stock is trading near the top of its 52‑week range, and Wall Street is sharpening its forecasts for 2026 and beyond. MRK stock price
Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Published: December 7, 2025 As the first full week of December wraps up, the Dow Jones Industrial Average is pressing up against the 48,000 line, sitting within striking distance of its all‑time highs. Investors are simultaneously cheering cooling inflation and a coming Federal Reserve rate cut, while parsing a thicket of 2026 forecasts that range from “bull market continues” to “recession risk rising.” This mix of optimism and unease is shaping the Dow Jones stock market narrative going into a pivotal week for Wall Street. Where the Dow Jones Stands Now The Dow Jones Industrial Average closed Friday, December 5,
7 December 2025
IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

As of December 7, 2025 The iShares Russell 2000 ETF (ticker: IWM) is back near its highs, trading around $250.77 after a powerful rebound in U.S. small‑cap stocks. The fund now sits close to its 52‑week peak near $252, up in the mid‑teens on a year‑to‑date basis, and well above its 52‑week low near $172. Investing.com+2Danelfin AI+2 At the same time, investors have poured billions into IWM, options activity has surged, and Wall Street strategists are suddenly bullish on small caps heading into 2026. So is IWM stock at the start of a new leadership cycle—or just another head fake
7 December 2025
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

As of 7 December 2025, Upstart Holdings (NASDAQ: UPST) sits right back in the market’s spotlight. The AI-powered consumer lender has delivered its strongest growth in years, secured multi‑billion‑dollar funding lines, and returned to GAAP profitability – yet its stock remains volatile, heavily shorted, and hotly debated on Wall Street. AlphaSense+1 This article rounds up the latest Upstart stock news, earnings, forecasts and analysis as of December 7, 2025, for readers tracking UPST on Google News and Discover. Upstart (UPST) stock price today: volatile AI lender with high short interest Upstart closed at about $46.75 per share in recent trading,
AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie’s stock is trading just below record highs as investors digest a powerful mix of rising earnings, a fresh dividend increase and a steady drumbeat of positive pipeline news in immunology, neuroscience and oncology. As of the close on Friday, December 5, 2025, AbbVie (NYSE: ABBV) finished at $226.08, down about 1.15% on the day and roughly 7–8% below its 52‑week high of $244.81 set on October 1.MarketWatch+1 That still leaves the company with a market capitalization around $400 billion, firmly placing it among the largest healthcare stocks globally.The Motley Fool+1 Below is a deep dive into the latest news,
Caterpillar (CAT) Stock on December 7, 2025: Record Highs, AI Tailwinds and 2026 Forecasts

Caterpillar (CAT) Stock on December 7, 2025: Record Highs, AI Tailwinds and 2026 Forecasts

Caterpillar Inc. (NYSE: CAT) goes into December 7, 2025 as one of the surprise “AI winners” of the year — even though it makes machines that move rock and dirt, not lines of code. The stock is trading a little above $600 per share, around $603, hovering near its record highs in the low $600s. Over the past year, CAT has climbed roughly 50%, with gains of more than 65% year‑to‑date and over 70% in the last six months, pushing its market cap beyond $270 billion. Yahoo Finance+3Investing.com+3TradingView+3 That kind of move naturally triggers the big investor questions: Let’s walk
7 December 2025

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop